Autoimmune liver disease involves the combined activity of multiple immune cell types in the liver, involving cells of the adaptive immune system, particularly antigen-specific Th1 cells, and cells of the innate immune system. We hypothesize that specific chemokines are critical for coordinating these cells in the autoimmune attack and mediate the progression from initial encounter of T cells with antigen to full-blown hepatocellular damage. The CXCR3 and CCR5 response pathways are important for mediating the chemotactic attraction of Th1 cells and we hypothesize that these pathways are critical for the development of autoimmune necroinflammatory liver disease. We test this hypothesis using a mouse model of spontaneously developing antigen-specific autoimmune T cell mediated hepatocellular damage. The BALB/c-TGF-21-/- mouse is a model of acute fulminant liver disease in a pediatric setting, and provides an excellent model system in which to address important questions relevant to T cell mediated liver damage. In this model system: liver damage develops spontaneously and rapidly;is mediated by antigen-specific Th1 cells;is associated with dramatic over-expression of specific chemokines that bind to CXCR3 and CCR5;and requires the activity of neutrophils. In this proposal, we address the relevance of specific chemokine pathways in liver disease, determine the mechanisms by which neutrophils accumulate in liver, and test whether a deficit in regulatory T cells is responsible for pathology.

Public Health Relevance

Autoimmune liver disease involves the combined activity of multiple immune cell types particularly Th1 cells and cells of the innate immune system. We hypothesize that small secreted molecules known as chemokines are important for initiating the influx of immune cells and the development of liver damage. In this project, we test the role of specific chemokine pathways, neutrophils, and regulatory T cells in the development of autoimmune hepatitis in mice lacking the protein TGF-21.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI078195-01A1
Application #
7581245
Study Section
Hepatobiliary Pathophysiology Study Section (HBPP)
Program Officer
Rothermel, Annette L
Project Start
2008-12-01
Project End
2013-11-30
Budget Start
2008-12-01
Budget End
2009-11-30
Support Year
1
Fiscal Year
2009
Total Cost
$399,750
Indirect Cost
Name
Dartmouth College
Department
Pathology
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Celaj, Stela; Gleeson, Michael W; Deng, Jie et al. (2014) The microbiota regulates susceptibility to Fas-mediated acute hepatic injury. Lab Invest 94:938-49
Maria, Ann; English, Kathryn A; Gorham, James D (2014) Appropriate development of the liver Treg compartment is modulated by the microbiota and requires TGF-? and MyD88. J Immunol Res 2014:279736
Cripps, James G; Celaj, Stela; Burdick, Marie et al. (2012) Liver inflammation in a mouse model of Th1 hepatitis despite the absence of invariant NKT cells or the Th1 chemokine receptors CXCR3 and CCR5. Lab Invest 92:1461-71
Cripps, James G; Gorham, James D (2011) MDSC in autoimmunity. Int Immunopharmacol 11:789-93
Cripps, James G; Wang, Jing; Maria, Ann et al. (2010) Type 1 T helper cells induce the accumulation of myeloid-derived suppressor cells in the inflamed Tgfb1 knockout mouse liver. Hepatology 52:1350-9
Milks, Michael W; Cripps, James G; Lin, Heping et al. (2009) The role of Ifng in alterations in liver gene expression in a mouse model of fulminant autoimmune hepatitis. Liver Int 29:1307-15